AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
BUSINESS NEWS.(TO THE POINT)
RETAIL
Wal-Mart sticks with growth plan
despite weak consumer spending
The world's largest retailer will add 40 million square feet of retail spacein the U.S. this year, even as some rivals shutter stores due to the weak economy. Wal-Mart also said at its annual meeting that it'll expand overseas through new stores and acquisitions. The discount retailer plans $9 billion in capital spending this year, unchanged from 2000.
Walmart.com to offer cheap Web access: It'll team up with AOL Time Warner's America Online to provide Internet access to its customers for less than $10 a month. Wal-Mart Connect will be launched this fall. AOL will hike its monthly price for unlimited use by $1.95 to $23.90 in July.
TRANSPORTATION
Daewoo union protests takeover
- FDA grants approval to Eli Lilly's Strattera.(RX RETAIL PHARMACY: Branded...
- Magazine article from: Chain Drug Review June 30, 2008 700+ words
INDIANAPOLIS -- Eli Lilly and Co. has received Food and Drug Administration clearance for Strattera (atomoxetine HCl) for maintenance treatment of attention-deficit/hyperactivity disorder (ADHD...
- FDA has no plans to review Lilly's Prozac. (Food and Drug Administration; Eli...
- Magazine article from: Chain Drug Review August 27, 1990 700+ words
...Despite the up-roar over Prozac, Eli Lilly & Co.'s antidepressant, the Food and Drug Administration says it has no plans at this time to...suggestive study. He does not believe Eli Lilly & Co. did as much as it should...
- Anxious dogs.(In 60 seconds)(Eli Lilly and Co. got Food and Drug Administration...
- Magazine article from: Feedstuffs May 14, 2007 700+ words
Eli Lilly & Co. recently received approval from the Food & Drug Administration to market Reconcile (fluoxetine hydrochloride), the first selective serotonin reuptake inhibitor class of antidepressants approved...
- Eli Lilly & Co.(Food and Drug Administration approval for Zyprexa)(Brief...
- Magazine article from: Chemical Market Reporter November 20, 2000 700+ words
OLANZAPINE--Eli Lilly & Co. has received US FDA approval for Zyprexa (olanzapine) for long-term therapy and maintenance of treatment response of schizophrenia
- Eli Lilly's Forteo, Strattera get food and drug administration nod. (Markets:...
- Magazine article from: Chemical Market Reporter Krause, Carey December 9, 2002 700+ words
ELI LILLY AND Company has received Food and Drug Administration (FDA) approval for Forteo and Strattera, ahead of early 2003 projections. The company reiterated full-year 2002 earnings...
- Eli Lilly and Co.(receives Food and Drug Administration approval for...
- Magazine article from: Medical Marketing & Media September 1, 2000 700+ words
Eli Lilly and Co.'s Sarafem (fluoxetine hydrochloride) for the treatment of premenstrual dysphoric disorder was approved by the FDA.
- Eli Lilly and Co.(receives Food and Drug Administration approval for Prozac...
- Magazine article from: Medical Marketing & Media April 1, 2001 700+ words
Eli Lilly and Co. announced FDA approval for Prozac in a weekly form. A weekly dosage for Prozac, used to treat depression, could mean long-term patient usage. Capsules will cost an estimated $18.95 each, five percent less than the daily dose for a week.
- FDA OKs Lilly's Forteo for osteoporosis. (Washington Insider).(U.S. Food and...
- Magazine article from: Medical Marketing & Media January 1, 2003 700+ words
The FDA in November approved the first new drug to stimulate new bone formation in patients with osteoporosis -- Eli Lilly and Co.'s Forteo (teriparatide). It is indicated to treat osteoporosis in postmenopausal women who are at high risk...